PRIORIX INJ. STŘÍKAČKA
INJ PLQ SOL ISP 25+25STŘ+50J
| SÚKL code | 0057523 |
|---|---|
| Name of the product | PRIORIX INJ. STŘÍKAČKA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | PRIORIX INJ. STŘÍKAČKA |
| Supplement | INJ PLQ SOL ISP 25+25STŘ+50J |
| Strenght | |
| Pharmaceutical form | Powder and solvent for solution for injection in prefilled syringe |
| Package | 25+25STŘ+50J |
| Route | Subcutaneous/intramucsular use |
| Language of the pack | Czech |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
LIVE ATTENUATED MEASLES VIRUS (VIRUS MORBILLORUM VIVUM ATTENUATUM) LIVE ATTENUATED MUMPS VIRUS (VIRUS PAROTITIDIS VIVUM ATTENUATUM) LIVE ATTENUATED RUBELLA VIRUS (VIRUS RUBELLAE VIVUM ATTENUATUM) |
| ATC group | J07BD52 |
| ATC group name | SPALNIČKY-PŘÍUŠNICE-ZARDĚNKY, ŽIVÁ ATENUOVANÁ VAKCÍNA |
Marketing authorisation information
| Registration Number | 59/ 739/99-A/C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | GlaxoSmithKline Biologicals S.A., Rixensart |
| MA Holder country | BELGIE |
cz